跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,589 条关于
“Maxim Group”
全部
26,589
临床试验
18,021
药物
559
机构
508
资讯
7,501
去年
Mediwound Receives Buy Rating Due to EscharEx's Market Potential
8个月前
IMUNON Secures $7 Million in Registered Direct Offering to Advance Phase 3 DNA-Mediated Immunotherapy
去年
Vivani Medical's Innovative GLP-1 Obesity Implant Garners Buy Ratings
去年
BrainStorm Cell Therapeutics Announces Update on Phase 3b NurOwn Trial for ALS
去年
Zevra Therapeutics Receives Buy Rating Following FDA Approval of Miplyffa for Niemann-Pick Disease Type C
去年
Alterity's ATH434 Shows Promise in Phase 2 Multiple System Atrophy Trial, Analyst Raises Price Target
去年
IceCure Medical's ProSense Receives Favorable FDA Panel Recommendation
2年前
Unicycive Therapeutics' OLC for Hyperphosphatemia Receives 'Buy' Rating Amidst NDA Submission
去年
VistaGen's Fasedienol Shows Promise in Phase 3 Trials for Social Anxiety Disorder
去年
Lymphir and Keytruda Combination Shows Promise in Advanced Lymphoma
第 1 页,共 751 页
上一页
下一页